These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 14654733)
1. Costs of implementing recommendations on hypertension management given in recent guidelines. Zanchetti A J Hypertens; 2003 Dec; 21(12):2207-9. PubMed ID: 14654733 [No Abstract] [Full Text] [Related]
2. [Economy, costs and drug choices in cardiology. A reflection on the 2012 position paper of the Italian Society of Hypertension]. Camerini F; Palcic S G Ital Cardiol (Rome); 2013 Jun; 14(6):412-5. PubMed ID: 23748537 [No Abstract] [Full Text] [Related]
3. Adherence and health care costs with single-pill fixed-dose combinations in hypertension management. Hilleman DE J Manag Care Pharm; 2014 Jan; 20(1):93-100. PubMed ID: 24372463 [No Abstract] [Full Text] [Related]
4. [Pharmacoeconomic aspects of the treatment of essential hypertension]. Martynov AI; Giliarevskiĭ SR; Ostroumova OD; Nesterova MV; Mamaev VI Ter Arkh; 2001; 73(9):82-8. PubMed ID: 11642090 [No Abstract] [Full Text] [Related]
5. [Comment on IOWiG report plan. A medical decision may not be replaced]. Vorstand der Deutschen Hochdruckliga E.V MMW Fortschr Med; 2006 May; 148(19):42. PubMed ID: 16736705 [No Abstract] [Full Text] [Related]
12. New European, American and International guidelines for hypertension management: agreement and disagreement. Stergiou GS; Salgami EV; ; ; Expert Rev Cardiovasc Ther; 2004 May; 2(3):359-68. PubMed ID: 15151482 [TBL] [Abstract][Full Text] [Related]
13. [A reply on subsidizing of antihypertensive agents: the problem is exceptional undertreatment of hypertension]. Willenheimer R; Nyström F; Berggren B; Lindström T; Cizinsky S; Weiss L Lakartidningen; 2008 Oct 22-28; 105(43):3055-6. PubMed ID: 19024623 [No Abstract] [Full Text] [Related]
14. Pharmacoeconomic considerations in the management of hypertension. Pardell H; Tresserras R; Armario P; Hernández del Rey R Drugs; 2000; 59 Suppl 2():13-20; discussion 39-40. PubMed ID: 10678593 [TBL] [Abstract][Full Text] [Related]
15. NIH promotes use of lower cost drugs for hypertension. Spurgeon D BMJ; 2004 Mar; 328(7439):539. PubMed ID: 15001483 [No Abstract] [Full Text] [Related]
16. Pharmacoeconomic evaluation of a pharmacist-managed hypertension clinic. Caro JJ; Lee K Curr Hypertens Rep; 2002 Dec; 4(6):418. PubMed ID: 12419167 [No Abstract] [Full Text] [Related]